Basis: Latest reported fiscal quarter. Source: stored company filings and market data; unavailable inputs remain N/A.
Is the quick ratio (acid-test) high or low?
The quick ratio (acid-test) of 12.12 is 57% above its 5-year average of 7.71, around the middle of its 5-year range (0.00–17.85).
As of the fiscal period ended Tuesday, June 30, 2026. 9.10% below its 12-month average of 13.33.
Reported quarterly quick ratio; no daily interpolation. Q2 FY2026 (2026-06-30): 12.12.
QUICK RATIO (ACID-TEST)
12.12
QUICK RATIO (ACID-TEST) AVG TTM
13.33
QUICK RATIO (ACID-TEST) AVG 3Y
9.18
QUICK RATIO (ACID-TEST) AVG 5Y
7.71
QUICK RATIO (ACID-TEST) AVG 10Y
N/A
QUICK RATIO (ACID-TEST) AVG 15Y
N/A
QUICK RATIO (ACID-TEST) AVG 20Y
N/A
CURRENT VS TTM AVG
-9.10%
CURRENT VS 3Y AVG
+32.00%
CURRENT VS 5Y AVG
+57.21%
CURRENT VS 10Y AVG
N/A
CURRENT VS 15Y AVG
N/A
CURRENT VS 20Y AVG
N/A
SECTOR MEDIAN · HEALTHCARE
3.19
median of 775 covered companies
CURRENT VS SECTOR MEDIAN
+279.94%
vs the sector median at left
Amylyx Pharmaceuticals, Inc.
Market Cap
$3.03B
Quick Ratio (Acid-Test)
12.12
TTM Avg
13.33
3Y Avg
9.18
5Y Avg
7.71
Market Cap
$3.05B
Quick Ratio (Acid-Test)
2.67
TTM Avg
3.48
3Y Avg
6.28
5Y Avg
8.36
Market Cap
$3.01B
Quick Ratio (Acid-Test)
64.07
TTM Avg
24.32
3Y Avg
16.73
5Y Avg
16.77
Market Cap
$3.10B
Quick Ratio (Acid-Test)
8.32
TTM Avg
8.81
3Y Avg
8.76
5Y Avg
9.71
Market Cap
$2.83B
Quick Ratio (Acid-Test)
12.02
TTM Avg
18.93
3Y Avg
12.46
5Y Avg
15.83
Market Cap
$2.81B
Quick Ratio (Acid-Test)
6.07
TTM Avg
7.05
3Y Avg
8.10
5Y Avg
8.04
Market Cap
$3.33B
Quick Ratio (Acid-Test)
17.91
TTM Avg
1.68
3Y Avg
1.68
5Y Avg
1.68
| NAME | MARKET CAP | QUICK RATIO (ACID-TEST) | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| Amylyx Pharmaceuticals, Inc. (AMLX) | $3.03B | 12.12 | 13.33 | 9.18 | 7.71 |
| Arcutis Biotherapeutics, Inc. (ARQT)vs › | $3.05B | 2.67 | 3.48 | 6.28 | 8.36 |
| Enliven Therapeutics, Inc. (ELVN)vs › | $3.01B | 64.07 | 24.32 | 16.73 | 16.77 |
| Denali Therapeutics Inc. (DNLI)vs › | $3.10B | 8.32 | 8.81 | 8.76 | 9.71 |
| Dyne Therapeutics, Inc. (DYN)vs › | $2.83B | 12.02 | 18.93 | 12.46 | 15.83 |
| TransMedics Group, Inc. (TMDX)vs › | $2.81B | 6.07 | 7.05 | 8.10 | 8.04 |
| AtriCure, Inc. (ATRC)vs › | $2.79B | 3.19 | 2.81 | 2.79 | 3.25 |
| Precigen, Inc. (PGEN)vs › | $2.72B | 3.89 | 3.79 | 3.02 | 3.31 |
| Parabilis Medicines, Inc. (PBLS)vs › | $3.33B | 17.91 | 1.68 | 1.68 | 1.68 |
| MBX Biosciences, Inc. Common Stock (MBX)vs › | $2.68B | 18.08 | 24.41 | 20.74 | 20.74 |
Quick Ratio
12.12
Excludes inventory
Current Ratio
12.12
Includes inventory
Quick Ratio = (Current Assets − Inventory) / Current Liabilities
The quick ratio is a stricter liquidity measure that excludes inventory, showing the ability to meet short-term obligations with the most liquid assets.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | QUICK RATIO (ACID-TEST) |
|---|---|
| 2026-06-30 | 12.12 |
| 2026-03-31 | 17.85 |
| 2025-12-31 | 14.27 |
| 2025-09-30 | 13.70 |
| 2025-06-30 | 8.72 |
| 2025-03-31 | 12.05 |
| 2024-12-31 | 6.67 |
| 2024-09-30 | 4.55 |
| 2024-06-30 | 4.66 |
| 2024-03-31 | 4.48 |
| 2023-12-31 | 5.20 |
| 2023-09-30 | 8.81 |
| 2023-06-30 | 6.28 |
| 2023-03-31 | 7.28 |
| 2022-12-31 | 7.99 |
| 2022-09-30 | 5.26 |
| 2022-06-30 | 7.96 |
| 2022-03-31 | 9.58 |
| 2021-12-31 | 6.03 |
| 2021-09-30 | 8.58 |
| 2021-06-30 | 0.00 |
| 2021-03-31 | 0.00 |
| 2020-12-31 | 0.00 |
